Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer

NCT02324088 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

174

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Breast Cancer

Interventions

DRUG: Docetaxel
DRUG: Cyclophosphamide
DRUG: Epirubicin

Sponsor

UNICANCER